Cargando…
A Comprehensive Review of the Pharmacologic Management of Uterine Leiomyoma
Uterine leiomyomata are the most common benign tumors of the gynecologic tract impacting up to 80% of women by 50 years of age. It is well established that these tumors are the leading cause for hysterectomy with an estimated total financial burden greater than $30 billion per year in the United Sta...
Autores principales: | Lewis, Terrence D., Malik, Minnie, Britten, Joy, San Pablo, Angelo Macapagal, Catherino, William H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893007/ https://www.ncbi.nlm.nih.gov/pubmed/29780819 http://dx.doi.org/10.1155/2018/2414609 |
Ejemplares similares
-
Retinoic acid treatment of human leiomyoma cells transformed the cell phenotype to one strongly resembling myometrial cells
por: Malik, Minnie, et al.
Publicado: (2008) -
Bladder leiomyoma presenting as uterine pedunculated leiomyoma
por: Nazari, Zeinab, et al.
Publicado: (2022) -
Uterine leiomyoma with tubules
por: Pusiol, Teresa, et al.
Publicado: (2008) -
Uterine Leiomyomas: An ENIGMA
por: Geethamala, Kempula, et al.
Publicado: (2016) -
Ultrasonography of uterine leiomyomas
por: Woźniak, Andrzej, et al.
Publicado: (2017)